An analysis of telephone interview data collected in 1992 from 820 women who reported problems with their breast implants to the food and drug administration

Plastic and Reconstructive Surgery

Volumn 109, Issue 6, 2002, Pages 2043-2051

  Coon, Sharon K ^a,b   Burris, Rebecca ^a,b   Coleman, Elizabeth Ann ^a,b   Lemon, Stephen J ^a,b  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b ARKANSAS TECH UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BREAST ENDOPROSTHESIS; CAUCASIAN; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FOOD AND DRUG ADMINISTRATION; HEALTH CARE PERSONNEL; HUMAN; MAJOR CLINICAL STUDY; PATIENT EDUCATION; PATIENT INFORMATION; PATIENT SATISFACTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; UNITED STATES;

EID: 0036254158     PISSN: 00321052     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006534-200205000-00040     Document Type: Article

References (55)

1. From the Food and Drug Administration
2. Silicone breast implant adverse event reports to the Food and Drug Administration
3. Tendency to capsular contracture around smooth and textured gel-filled silicone mammary implants: A five-year follow-up
4. Failure of silicone gel breast implants: Analysis of literature data for 1652 explanted prostheses
5. Cosmetic and postmastectomy breast implants: Finnish women's experiences
6. Silicone gel breast implant failure and frequency of additional surgeries: Analysis of 35 studies reporting examination of more than 8,000 explants
7. A clinical and immunologic evaluation of women with silicone breast implants and symptoms of rheumatic disease
8. Human adjuvant disease following augmentation mammoplasty
9. Rheumatic disease among 1167 women reporting local implant and systematic problems after breast implant surgery
10. Risk of connective-tissue disease and other disorders after breast implantation
11. A descriptive analysis of physical complaints from women with silicone breast implants
12. Scleroderma following augmentation mammoplasty: Report of a case and review of the literature
13. Scleroderma after silicone augmentation mammoplasty
14. Augmentation mammaplasty associated with a severe systemic illness
15. Post-mammoplasty connective tissue disease
16. Systemic sclerosis after augmentation mammoplasty with silicone implants
17. A retrospective cohort study of implanted medical devices and selected chronic diseases in Medicare claims data
18. Self-reported breast implants and connective-tissue diseases in female health professionals: A retrospective cohort study
19. Self-reported symptoms among women after cosmetic breast implant and breast reduction surgery
20. Silicone gel breast implant rupture, extracapsular silicone, and health status in a population of women
21. Meta-analyses of the relation between silicone breast implants and the risk of connective-tissue diseases
22. A formal risk assessment of silicone breast implants
23. Silicon analysis of breast and capsular tissue from patients with saline or silicone gel breast implants: II. Correlation with connective-tissue disease
24. From cadavers to implants: Silicon tissue assays of medical devices
25. Does long-term exposure to gel-filled silicone implants increase the risk of relapse after breast cancer?
26. Are breast implants anticarcinogenic? A 14-year follow-up of the Los Angeles study
27. Breast enlargement and reduction: Results from a breast cancer case-control study
28. Breast augmentation: A risk factor for breast cancer?
29. The relationship between breast cancer and augmentation mammoplasty: An epidemiologic study
30. Cancer risk at sites other than the breast following augmentation mammoplasty
31. Mortality among augmentation mammoplasty patients
32. Silicone controversy: A survey of women with breast cancer and silicone implants
33. Determinants of patient satisfaction in postmastectomy breast reconstruction
34. Toward understanding women who request removal of silicone breast implants
35. The basis of the FDA's decision on breast implants
36. Introducing MEDwatch: A new approach to reporting medication and device adverse effects and product problems
37. Impact of silicone implants on the lives of women with breast cancer
38. Misleading presentation of breast cancer in popular magazines
39. How the media influences women's perceptions of health care
40. Mammography messages in popular media: Implications for patient expectations and shared clinical decision-making
41. Patient non-compliance: Deviance or reasoned decision making?
42. Ally, advocate, analyst, agenda-setter? Positions and perceptions of Swedish medical journalists
43. Health promotion in primary care: Physician-patient communication and decision making about prescription medications
44. The increasing popularity of cosmetic surgery procedures: A look at statistics in plastic surgery
45. Saline-filled breast implant safety and efficacy: A multicenter retrospective review